3rd Quarter - Report — F. HOFFMANN-LA ROCHE LTD, AND ITS AFFIL… for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIA… (2016)

Firm

F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES

Client

F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES

Income

—

Expenses

$90,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

HR 771: Protecting Access to Diabetic Testing Supplies Act of 2015. Yet to be introduced proposal on Medicare Competitive Bidding related to diabetes testing supplies. Legislation affecting Medicare payments for laboratory services.

Lobbyist	Covered position, as disclosed
RUSSELL CONWELL RING	—
BRUCE THOMAS TAYLOR	—
RAVI UPADHYAY	—

Contacted: HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 771 (114th)

Pharmacy PHA

H.R. 771 - Protecting Access to Diabetic Testing Supplies Act of 2015. Yet to be introduced Senate proposal on Medicare Competitive Bidding related to diabetes testing supplies.

Lobbyist	Covered position, as disclosed
RUSSELL CONWELL RING	—
BRUCE THOMAS TAYLOR	—
RAVI UPADHYAY	—

Contacted: Food & Drug Administration (FDA); Government Accountability Office (GAO); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 771 (114th)

Health Issues HCR

H.R.6-21st Century Cures Act; Yet to be introduced House proposal to have the FDA regulate laboratory developed tests; Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests; H.R. 771-Protecting Access to Diabetes Supplies Act of 2015; Yet to be introduced Senate proposal on Medicare competitive bidding proposal related to diabetes supplies.

Lobbyist	Covered position, as disclosed
RUSSELL CONWELL RING	—
BRUCE THOMAS TAYLOR	—
RAVI UPADHYAY	—

Contacted: Government Accountability Office (GAO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 771 (114th), H.R. 6 (114th)

Medical/Disease Research/Clinical Labs MED

Yet to be introduced House proposal to have FDA regulate lab developed tests. Yet to be introduced Senate proposal to have FDA regulate lab developed tests.

Lobbyist	Covered position, as disclosed
RUSSELL CONWELL RING	—
RAVI UPADHYAY	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.